Ben Jones of PCI Pharma Services explores the attractiveness of the US drug market for selling pharmaceutical therapies. With a population of more than 330 million people, it is valued at $358 billion annually and represents approximately 44% of the total global pharmaceutical market. Pharmaceutical companies operating in the United States are now expected to have taken
initial steps in securing their supply chain, complying with the Drug Safety and Supply Chain Act (DSCSA) effective November of 2017.

 

Comments are closed.

%d bloggers like this: